W
CORV

Wealthfront’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Wealthfront’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-1
Closed – – 1508
2015
Q2 		$0 Buy
+1
New +$9 ﹤0.01% 1412

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return
AIS
AlphaOne Investment Services West Chester, Pennsylvania $79.5M AUM 49.42% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

Wealthfront's CORV Position: Q3 2015 in Review

Wealthfront sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q3 2015, closing a stake of 1 share.

Wealthfront first reported a position in CORV in Q2 2015 and held it in 1 quarter. The position peaked at $0 in Q2 2015. 30 funds tracked by Wall St. Rank hold CORV as of Q3 2015.

  • Wealthfront reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q3 2015 after selling out during the quarter.
  • Wealthfront sold 1 Correvio Pharma Corp. Ordinary Shares (Canada) share in Q3 2015.
  • Wealthfront first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q2 2015 and held it in 1 quarter.
  • Wealthfront's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $0 in Q2 2015.
  • 30 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q3 2015.

Based on Wealthfront's 13F filing for Q3 2015, filed 18 Nov 2015.